Clinical Trial Update: The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether intra-operative ketorolac affects hematoma rates in breast reduction surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Reduction Complications
• Hematoma Postoperative

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Dr. Chandran Medical Prof Corp | Conditions: Hematoma Postoperative | Phase 4 | Status: UNKNOWN